As of May 30, 2023, Morgan Stanley has retracted its May 23 price target headline on BHG. However, analyst Ricky Goldwasser still maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and has lowered the price target from $12800 to $160. This comes after a report on May 19, 2023, stating that Morgan Stanley maintains a $2 price target on BHG shares and that any reports of a PT raise were erroneous. Despite this, Morgan Stanley has still kept coverage of Target (NYSE:TGT) with an Equal-Weight recommendation. In terms of American Express, Morgan Stanley believes that its current valuation is too high and that its price target of $188 implies a 24.4% increase in shares in the near future.
BHG Stock Update: Negative Earnings Growth Last Year, Positive Growth This Year, and Expected Growth in the Next Five Years
On May 30, 2023, BHG stock opened at 11.12, down from the previous close of 11.77, with a day’s range of 9.25 – 11.12 and a volume of 312,842 shares traded. The market cap of BHG was $102.1M. The company had a negative earnings growth of 26.03% last year, but has shown a positive growth of 70.62% this year. BHG is expected to show a growth rate of 41.11% in the next five years. The revenue growth rate for the past year was negative at 40.14%. BHG does not have a P/E ratio available, and the price/sales ratio is 0.17. The next reporting date for BHG is August 1, 2023, and the EPS forecast for this quarter is -$0.07. BHG operates in the health services sector and the managed health care industry.
Bright Health Group Inc Stock Analysis: Median Target Price Indicates Significant Decrease in Value
On May 30, 2023, Bright Health Group Inc (BHG) had a median target price of $1.00, according to data from CNN Money. This represents a -89.19% decrease from the last price of $9.25. The 5 analysts offering 12-month price forecasts for BHG had a high estimate of $13.00 and a low estimate of $0.40.
The current consensus among 7 polled investment analysts is to hold stock in BHG. This rating has held steady since May, when it was unchanged from a hold rating. This indicates that there is no clear direction for the stock at this time, and investors are advised to hold onto their positions.
In terms of earnings, BHG reported a loss of -$0.07 per share for the current quarter, with sales of $751.6 million. The company is set to report its earnings on August 01, 2023.
Overall, BHG’s stock performance on May 30, 2023, was lackluster, with a median target price that suggests a significant decrease in value. However, the hold rating from investment analysts indicates that there may not be a clear direction for the stock at this time. Investors should keep an eye on the company’s upcoming earnings report to gain a better understanding of its financial health and potential for growth.
Source: beststocks.com
